We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Resmed Cdi 10:1 | ASX:RMDCD | Australian Stock Exchange | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0 | - |
From Jun 2019 to Jun 2024
By Rebecca Thurlow
SYDNEY--Fisher & Paykel Healthcare Corp. (FPH.NZ) said Tuesday it has filed patent infringement proceedings in a U.S. court against ResMed Inc. (RMD.AU)
The company alleges certain of ResMed's continuous positive airway pressure devices and accessories used in the treatment of patients with obstructive sleep apnea, and certain of ResMed's masks, infringe on Fisher & Paykel Healthcare patents.
ResMed wasn't immediately available to comment.
-Write to Rebecca Thurlow at rebecca.thurlow@wsj.com
(END) Dow Jones Newswires
August 15, 2016 18:48 ET (22:48 GMT)
Copyright (c) 2016 Dow Jones & Company, Inc.
1 Year Resmed Cdi 10:1 Chart |
1 Month Resmed Cdi 10:1 Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
